Ground Swell Capital’s Pacira BioSciences PCRX Stock Holding History

Ground Swell Capital’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-567	Closed	-$52K	–	2669
2014 Q2	$52K	Buy	+567	New	+$43.2K	0.1%	136

Other funds holding PCRX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCM

Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ground Swell Capital's PCRX Position: Q3 2014 in Review

Ground Swell Capital sold out of Pacira BioSciences (PCRX) in Q3 2014, closing a stake of 567 shares — an estimated $52K sold.

Ground Swell Capital first reported a position in PCRX in Q2 2014 and held it in 1 quarter. The position peaked at $52K in Q2 2014. 208 funds tracked by Wall St. Rank hold PCRX as of Q3 2014.

Ground Swell Capital reported no remaining Pacira BioSciences position as of Q3 2014 after selling out during the quarter.
Ground Swell Capital sold 567 Pacira BioSciences shares in Q3 2014, an estimated $52K.
Ground Swell Capital first reported a position in Pacira BioSciences in Q2 2014 and held it in 1 quarter.
Ground Swell Capital's Pacira BioSciences position peaked at $52K in Q2 2014.
208 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.